These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36176402)

  • 1. A detection panel of novel methylated DNA markers for malignant pleural effusion.
    Liang C; Liu N; Zhang Q; Deng M; Ma J; Lu J; Yin Y; Wang J; Miao Y; She B; Li Q; Hou G
    Front Oncol; 2022; 12():967079. PubMed ID: 36176402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Methylation Analysis of the
    Zhang N; Liu Z; Li K; Xing X; Long C; Liu F; She B; Che N
    J Oncol; 2023; 2023():5888844. PubMed ID: 36691467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
    Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
    PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHOX2 DNA methylation is a tumour marker in pleural effusions.
    Ilse P; Biesterfeld S; Pomjanski N; Fink C; Schramm M
    Cancer Genomics Proteomics; 2013; 10(5):217-23. PubMed ID: 24136974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.
    Jung M; Pützer S; Gevensleben H; Meller S; Kristiansen G; Dietrich D
    Clin Epigenetics; 2016; 8():24. PubMed ID: 26937257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
    Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
    Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.
    Zhang C; Yu W; Wang L; Zhao M; Guo Q; Lv S; Hu X; Lou J
    J Cancer; 2017; 8(17):3585-3591. PubMed ID: 29151944
    [No Abstract]   [Full Text] [Related]  

  • 8. Performance Evaluation of
    Shi J; Chen X; Zhang L; Fang X; Liu Y; Zhu X; Zhang H; Fan L; Gu J; Zhang S; She B; Han H; Yi X
    Front Oncol; 2020; 10():565780. PubMed ID: 33425721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.
    Ni S; Ye M; Huang T
    Oncotarget; 2017 Sep; 8(37):61253-61263. PubMed ID: 28977861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
    Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
    Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
    [No Abstract]   [Full Text] [Related]  

  • 11. The Diagnostic Potential of
    Gao H; Yang J; He L; Wang W; Liu Y; Hu Y; Ge M; Ding J; Ye Q
    Front Oncol; 2022; 12():849024. PubMed ID: 35837113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of long noncoding RNA
    Wang WW; Zhou XL; Song YJ; Yu CH; Zhu WG; Tong YS
    Onco Targets Ther; 2018; 11():2333-2344. PubMed ID: 29731641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion.
    Katayama H; Hiraki A; Aoe K; Fujiwara K; Matsuo K; Maeda T; Murakami T; Toyooka S; Sugi K; Ueoka H; Tanimoto M
    Int J Cancer; 2007 May; 120(10):2191-5. PubMed ID: 17285579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer.
    Li N; Zeng Y; Huang J
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1379-1393. PubMed ID: 32266538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
    Biaoxue R; Min L; Tian F; Wenlong G; Hua L
    BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
    Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
    Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
    Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
    J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?
    Brock MV; Hooker CM; Yung R; Guo M; Han Y; Ames SE; Chang D; Yang SC; Mason D; Sussman M; Baylin SB; Herman JG
    Ann Thorac Surg; 2005 Oct; 80(4):1241-7. PubMed ID: 16181847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.